Global

Chemistry Experts

Zervou Maria

Researcher
Institute of Biology, Medicinal Chemistry and Biotechnology
Athens
Greece

Biography

 2002: Ph.D. Chemistry, University of Patras 1992: M.Sc. Electronic Engineering, Department of Physics, University of Athens 1989: B.Sc. Physics, University of Athens Appointments 2013-present: Researcher B' at the Institute of Biology, Medicinal Chemistry and Biotechnology, National Hellenic Research Foundation, Athens 2006-2013: Researcher C' at the Organic and Pharmaceutical Chemistry, National Hellenic Research Foundation, Athens 2003-2006: Special Functional Scientist at the Organic and Pharmaceutical Chemistry, National Hellenic Research Foundation, Athens 1992-2003: Special Technical Scientist at the Organic and Pharmaceutical Chemistry, National Hellenic Research Foundation, Athens 

Research Interest

 Research Interests  Drug design by applying NMR spectroscopy and in silico studies. Synergistic use of Bio-NMR and molecular modeling. Topics: antihypertensive AT1 antagonists, aspatic-protease inhibitors, DHEA neurosteroid analogs, glycogen phosphorylase inhibitors, bioactive peptides. Studies also address new repellents for the malaria-transmitting mosquito A.gambiae.  NMR- and LC-MS based metabolomics. Topics: metabolomics in algae research, applications in high added-value natural products as traditional beverages  Structure elucidation of novel bioactive metabolites of plant or marine origin, structure characterization of metal-ligand complexes and nanostructures.

Publications

  • 3. C. Fotakis, D. Christodouleas, K. Kokkotou, M. Zervou*, P. Zoumpoulakis, P. Moulos, M. Liouni, A. Calokerinos. NMR metabolite profiling of Greek grape marc spirits. Food Chemistry 2013, 138, 1837–1846

  • 2. M. Zervou*, Z. Cournia, C. Potamitis, G. Patargias, S. Durdagi, S. Golic Grdadolnik, T. Mavromoustakos. Insights into the Molecular Basis of Action of the AT1 Antagonist Losartan Using a Combined NMR Spectroscopy and Computational Approach. BBA Biomembranes, doi: 10.1016/j.bbamem.2013.12.012, (2013).

  • 1. M. Mondal, N. Radeva, H. Koster, A. Park, C. Potamitis, M. Zervou, G. Klebe, A. K. H. Hirsch. Structure-Based Design of Novel Inhibitors of the Aspartic Protease Endothiapepsin Exploiting Dynamic Combinatorial Chemistry. Angew Chem Int Ed, Accepted (2014)

Global Experts from Greece

Global Experts in Subject

Share This Profile
Recent Expert Updates
  • Matthew L Stone
    Matthew L Stone
    pediatrics
    University of Virginia Health System; Charlottesville, VA
    United States of America
  • Dr.   Matthew
    Dr. Matthew
    pediatrics
    University of Virginia Health System; Charlottesville, VA
    United States of America
  • Dr.  L Stone Matthew
    Dr. L Stone Matthew
    pediatrics
    University of Virginia Health System; Charlottesville, VA
    United States of America
  • Dr.  L Stone
    Dr. L Stone
    pediatrics
    University of Virginia Health System; Charlottesville, VA
    United States of America
  • Dr. Matthew L Stone
    Dr. Matthew L Stone
    pediatrics
    University of Virginia Health System; Charlottesville, VA
    United States of America
  • Dr.  R Sameh
    Dr. R Sameh
    pediatrics
    King Abdul Aziz University
    United Arab Emirates
  • Dr.   R Ismail,
    Dr. R Ismail,
    pediatrics
    King Abdul Aziz University
    United Arab Emirates
  • Sameh R Ismail,
    Sameh R Ismail,
    pediatrics
    King Abdul Aziz University
    United Arab Emirates
  • Dr.   Sameh R Ismail,
    Dr. Sameh R Ismail,
    pediatrics
    King Abdul Aziz University
    United Arab Emirates
  • Dr.   William
    Dr. William
    pediatrics
    Maimonides Medical Center
    United States of America